Vis enkel innførsel

dc.contributor.authorSulheim, Einar
dc.contributor.authorHanson, Ingunn
dc.contributor.authorSnipstad, Sofie
dc.contributor.authorVikedal, Krister
dc.contributor.authorMørch, Ýrr Asbjørg
dc.contributor.authorBoucher, Yves
dc.contributor.authorDavies, Catharina de Lange
dc.date.accessioned2022-03-24T09:46:26Z
dc.date.available2022-03-24T09:46:26Z
dc.date.created2021-09-27T14:36:03Z
dc.date.issued2021
dc.identifier.citationAdvanced therapeutics. 2021, 4 (10), .en_US
dc.identifier.issn2366-3987
dc.identifier.urihttps://hdl.handle.net/11250/2987266
dc.description.abstractDrug delivery to tumors is challenging due to biological barriers obstructing effective delivery. Sonopermeation with ultrasound and microbubbles has been shown to improve therapeutic effect of many classes of drugs, but the underlying mechanism is not fully understood. In this study, two subcutaneous xenograft tumor models, that differed substantially in blood vessel density and stiffness, is treated with poly(alkyl cyanoacrylate) nanoparticles and nanoparticle-stabilized microbubbles combined with ultrasound. Improved nanoparticle accumulation and extracellular matrix (ECM) penetration is found. The stiffness and solid stress in the tumors are measured and it is discovered that sonopermeation can reduce the solid stress in both models, with the highest effect in the stiffest tumor model. This suggests that sonopermeation affects not only the blood vessel wall which has been described previously, but also the ECM to reduce solid stress and increase diffusion and transport of nanomedicines.en_US
dc.language.isoengen_US
dc.publisherWiley-VCH GmbHen_US
dc.rightsNavngivelse 4.0 Internasjonal*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/deed.no*
dc.titleSonopermeation with nanoparticle-stabilized microbubbles reduces solid stress and improves nanomedicine delivery to tumorsen_US
dc.typePeer revieweden_US
dc.typeJournal articleen_US
dc.description.versionpublishedVersionen_US
dc.rights.holder© 2021 The Authors.Advanced Therapeuticspublished by Wiley-VCHGmbH. This is an open access article under the terms of the CreativeCommons Attribution License, which permits use, distribution andreproduction in any medium, provided the original work is properly cited.en_US
dc.source.pagenumber12en_US
dc.source.volume4en_US
dc.source.journalAdvanced therapeuticsen_US
dc.source.issue10en_US
dc.identifier.doi10.1002/adtp.202100147
dc.identifier.cristin1939164
dc.relation.projectNorges forskningsråd: 262228en_US
dc.relation.projectHelseforetak: 46084000en_US
dc.source.articlenumber2100147en_US
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode1


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel

Navngivelse 4.0 Internasjonal
Med mindre annet er angitt, så er denne innførselen lisensiert som Navngivelse 4.0 Internasjonal